Fluorogenic Peptide‐Based Substrates for Monitoring Thrombin Activity
- 31 January 2012
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 7 (4), 606-617
- https://doi.org/10.1002/cmdc.201100560
Abstract
The synthesis of a series of peptides containing C-terminal 7-amino-4-methylcoumarin (AMC) for use in the thrombin generation test (TGT) is described. The lead structure in this project was H-Gly-Gly-Arg-AMC, of which the water solubility and kinetic parameters (KM and kcat) are greatly improved over those of the substrate in current use in the TGT: Cbz-Gly-Gly-Arg-AMC. A series of N-terminally substituted Gly-Gly-Arg-AMC derivatives were synthesized, as well as implementation of structural changes at either the P2 or P3 position of the peptide backbone. Furthermore, two substrates were synthesized that have structural similarities to the chromogenic thrombin substrate SQ68 or that contain a 1,2,3-triazole moiety in the peptide chain, mimicking an amide bond. To determine the applicability of newly synthesized fluorogenic substrates for monitoring continuous thrombin generation, the KM and kcat values of the conversion of these fluorogenic substrates by thrombin (FIIa) and factor Xa (FXa) were quantified. An initial selection was made on basis of these data, and suitable substrates were further evaluated as substrates in the thrombin generation assay. Assessment of the acquired data showed that several substrates, including the SQ68 derivative Et-malonate-Gly-Arg-AMC and N-functionalized Gly-Gly-Arg-AMC derivatives, are suitable candidates for replacement of the substrate currently in use.Keywords
This publication has 82 references indexed in Scilit:
- Synthesis and aggregation behavior of biohybrid amphiphiles composed of a tripeptidic head group and a polystyrene tailSoft Matter, 2009
- Differential Effects of Factor IIa Inhibitors on the Endogenous Thrombin PotentialTherapeutic Drug Monitoring, 2008
- Pharmacology of emerging novel platelet inhibitorsAmerican Heart Journal, 2008
- Caution in the interpretation of continuous thrombin generation assays: a rebuttalJournal of Thrombosis and Haemostasis, 2007
- Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BThrombosis and Haemostasis, 2005
- The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) productionBioorganic & Medicinal Chemistry Letters, 2003
- Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasmaThrombosis and Haemostasis, 2003
- A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal AlkynesAngewandte Chemie-International Edition, 2002
- Highly sensitive peptide‐4‐methylcoumaryl‐7‐amide substrates for blood‐clotting proteases and trypsinEuropean Journal of Biochemistry, 1988
- Synthesis of a key fluorogenic amide, L-arginine-4-methylcoumaryl-7-amide (L-Arg-MCA) and its derivatives. Fluorescence assays for trypsin and papain.CHEMICAL & PHARMACEUTICAL BULLETIN, 1977